Migraine Briefs

Chronic migraine: Medication-overuse headache linked to increased suicidal risks


 

Key clinical point: Medication-overuse headache (MOH) was associated with an increased risk for suicidal ideation and prior suicide attempt in patients with chronic migraine (CM).

Major finding: The presence of MOH increased the risks for suicidal ideation (odds ratio [OR], 1.75; P = .004) and prior suicide attempt (OR, 1.88; P = .024) in patients with CM.

Study details: Findings are from a cross-sectional study of 603 patients with CM with (n=320) or without (n=283) coexisting MOH.

Disclosures: The study was supported in part by the Taiwan Ministry of Science and Technology, Taipei Veterans General Hospital, and others. YF Wang and SJ Wang reported receiving honoraria and/or research grants from and serving on advisory boards for multiple sources. Three other authors had no disclosures.

Source: Wang YF et al. J Headache Pain. 2021 May 10. doi: 10.1186/s10194-021-01248-0 .

Recommended Reading

Chronic headache pain in veterans linked to suicide attempts
Migraine ICYMI
Migraine linked to more COVID-19 infections, symptoms but less health care utilization
Migraine ICYMI
Ubrogepant effective for acute migraine even with preventive monoclonal antibody therapy
Migraine ICYMI
Moving more, sitting less vital for migraine patients
Migraine ICYMI
Erenumab reduces migraine attacks and not just migraine days
Migraine ICYMI
Chronic migraine: Efficacy and safety of CGRP slightly better than botulinum toxin
Migraine ICYMI
Erenumab shows long-term promise in episodic migraine patients with prior treatment failures
Migraine ICYMI
Migraine: Repeated transcranial direct current stimulation effectively reduces pain intensity
Migraine ICYMI
Fremanezumab beneficial for patients with migraine and comorbid depression
Migraine ICYMI
Galcanezumab shows promise in a real-life cohort of patients with migraine
Migraine ICYMI